Thursday August 16, 2018

High BP Medicine May Help Treat Migraine

Migraines are thought to affect a staggering one billion people worldwide

0
//
35
High BP Medicine May Help Treat Migraine
High BP Medicine May Help Treat Migraine. Pixabay
Republish
Reprint

A medication originally used to treat high blood pressure may help you from migraine pain attacks.
Candesartan – a drug used to treat high blood pressure – is just as effective as the commonly prescribed propranolol for migraine sufferers, according to a study.

The researchers also found that candesartan may work for patients who get no relief from propranolol.

“This gives doctors more possibilities and we can help more people,” said professor Lars Jacob Stovner, from Norwegian University of Science and Technology (NTNU).

“Candesartan is already in use by several doctors as a migraine preventive medicine but our follow-up study provides the proof that the drug actually works as a treatment,” said the researchers.

Representational image.
Representational image. Pixabay

The NTNU study was a triple blind test, which means that neither patients nor doctors nor those who analysed the results knew whether the patients had been given placebo or real medicine, Stovner said.

Researchers tested both candesartan and propranolol in 72 patients.

These patients were normally affected by migraine attacks at least twice every month.

The patients used each treatment (candesartan, propranolol or placebo) for 12 weeks.

More than 20 percent of migraine patients reported that they feel better even when they are given a placebo.

Also Read: Why migraines are more common among women

But blind tests show that candesartan works preventively for another 20 to 30 percent of patients.

“The hope is now that candesartan will be even more commonly prescribed,” said Stovner.

Migraines are thought to affect a staggering one billion people worldwide. (IANS)

Click here for reuse options!
Copyright 2018 NewsGram

Next Story

Antibiotics Most Frequently Prescribed Medicine Worldwide

Considering most countries have laws prohibiting over-the-counter sales of antibiotics, there is a need to ensure such laws are more strictly enforced where appropriate

0
The study found that between 2000 and 2010, the consumption of antibiotics increased globally from 50 billion to 70 billion standard units.
The study found that between 2000 and 2010, the consumption of antibiotics increased globally from 50 billion to 70 billion standard units. (IANS)

The increased over-the-counter supply of antibiotics in many countries including India, is worsening antibiotic resistance globally, finds a study highlighting an urgent need for better enforcement of laws.

The study found that between 2000 and 2010, the consumption of antibiotics increased globally from 50 billion to 70 billion standard units.

A majority of overall increase occurred in India, China, Brazil, Russia and South Africa.

“This overuse of antibiotics could facilitate the development and spread of antibiotic resistance. In India, for example, about 57,000 neonatal sepsis deaths occurring annually are due to antibiotic-resistant infections,” said Emmanuel Adewuyi, from the Queensland University of Technology in Australia.

It accounts for more than two million infections and 23,000 deaths annually in the US, and around 25,000 deaths in Europe each year.

A majority of overall increase occurred in India, China, Brazil, Russia and South Africa.
A majority of overall increase occurred in India, China, Brazil, Russia and South Africa. (IANS)

“Reliable estimates of the burden of antibiotic-resistant infections in developing countries are lacking but it is believed to cause many more deaths in these countries,” Adewuyi added.

For the study, published in The Journal of Infection, the team analysed studies from 24 countries.

The study found that antibiotics supplied without prescription were largely for the treatment of acute and self-limited conditions such as upper respiratory tract infections and gastroenteritis.

Also Read: Oral Antibiotics Possess Threat of Kidney Stones

“Many were also broad-spectrum antibiotics like amoxicillin, azithromycin and others which increase the risk of development of difficult-to-treat infections like the deadly methicillin resistant Staphylococcus aureus,” Adewuyi said.

“Such practice not only predisposes patients to inappropriate drug and dose choices, it portends great risks for the development and spread of resistant organisms, masking of diagnosis as well as delayed hospital admissions,” said Asa Auta from the University of Central Lancashire in Britain.

“Considering most countries have laws prohibiting over-the-counter sales of antibiotics, there is a need to ensure such laws are more strictly enforced where appropriate,” Adewuyi noted. (IANS)